Top Markets
Coin of the day
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Pozycja w akcjach #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Cena akcji
$0.1
Ostatnia synchronizacja: 2024-06-18
Kapitalizacja rynkowa
$1.31M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Pascal Biosciences Inc. (PSCBF)

Kategoria

Zyski dla Pascal Biosciences Inc. (PSCBF)
Zyski w Feb 2024 TTM: $-247.59K
Według najnowszych raportów finansowych Pascal Biosciences Inc., obecny zysk firmy wynosi $-247.59K. W roku 2022 firma osiągnęła zysk w wysokości $-359.87K, wzrost w porównaniu do zysku z roku 2021, który wynosił $-853.00K. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Pascal Biosciences Inc. od 2019 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-247.59K -15.84%
2023 $-294.20K -18.25%
2022 $-359.87K -57.81%
2021 $-853.00K -9.78%
2020 $-945.48K -63.20%
2019 $-2.57M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$5.27B -2,130,610.56%
US
$1.95B -787,959.61%
NL
- -
CH
- -
KR
$3.01B -1,214,096.90%
BE